Cogent Biosciences Statistics
Share Statistics
Cogent Biosciences has 113.86M
shares outstanding. The number of shares has increased by 19.07%
in one year.
| Shares Outstanding | 113.86M |
| Shares Change (YoY) | 19.07% |
| Shares Change (QoQ) | 3.07% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 9 |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 15.58M, so 13.68% of the outstanding
shares have been sold short.
| Short Interest | 15.58M |
| Short % of Shares Out | 13.68% |
| Short % of Float | 16.02% |
| Short Ratio (days to cover) | 15.64 |
Valuation Ratios
The PE ratio is -3.17 and the forward
PE ratio is -2.93.
Cogent Biosciences's PEG ratio is
-0.07.
| PE Ratio | -3.17 |
| Forward PE | -2.93 |
| PS Ratio | 0 |
| Forward PS | 1.1 |
| PB Ratio | 3.16 |
| P/FCF Ratio | -3.89 |
| PEG Ratio | -0.07 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Cogent Biosciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.32,
with a Debt / Equity ratio of 0.07.
| Current Ratio | 5.32 |
| Quick Ratio | 5.32 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | -0.06 |
| Debt / FCF | -0.08 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,248,092.68 |
| Employee Count | 205 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -34.32% in the
last 52 weeks. The beta is 0.22, so Cogent Biosciences's
price volatility has been higher than the market average.
| Beta | 0.22 |
| 52-Week Price Change | -34.32% |
| 50-Day Moving Average | 5.13 |
| 200-Day Moving Average | 8.3 |
| Relative Strength Index (RSI) | 61.44 |
| Average Volume (20 Days) | 1,354,361 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -275.94M |
| Net Income | -255.86M |
| EBITDA | -275.94M |
| EBIT | -275.94M |
| Earnings Per Share (EPS) | -3.49 |
Full Income StatementBalance Sheet
The company has 98.17M in cash and 17.47M in
debt, giving a net cash position of 80.7M.
| Cash & Cash Equivalents | 98.17M |
| Total Debt | 17.47M |
| Net Cash | 80.7M |
| Retained Earnings | -859.48M |
| Total Assets | 283.8M |
| Working Capital | 203.57M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -207.79M
and capital expenditures -573K, giving a free cash flow of -208.36M.
| Operating Cash Flow | -207.79M |
| Capital Expenditures | -573K |
| Free Cash Flow | -208.36M |
| FCF Per Share | -2.01 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
